Inflammation Genomics and Atherosclerosis
炎症基因组学和动脉粥样硬化
基本信息
- 批准号:6534706
- 负责人:
- 金额:$ 58.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-16 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:African American DNA acute phase protein atherosclerosis body physical activity calcification cardiovascular disorder epidemiology caucasian American clinical research coronary artery coronary disorder disease /disorder onset fibrinogen functional /structural genomics gene environment interaction gene interaction genetic polymorphism genetic susceptibility genotype human data human genetic material tag human middle age (35-64) human population genetics inflammation obesity racial /ethnic difference smoking thrombosis
项目摘要
DESCRIPTION (provided by applicant): Advances in biology suggest that atherosclerosis may reflect, in part, the vascular consequences of chronic inflammation. Using information on complete sequence variation and common haplotypes on a set of candidate genes generated through the NHLBI Program in Genomic Applications (PGA) at the University of Washington, we propose to examine the associations of common variation in inflammation/thrombosis genes with intermediate quantitative phenotypes and subclinical coronary atherosclerosis in the Coronary Artery Risk Factor Development in Young Adult (CARDIA) Study, a large, bi-racial cohort study. The set of 25 candidate genes involve pathways (cytokines, chemokines, and their receptors; cellular adhesion molecules; and, coagulation proteins) and include several receptor-ligand pairs. Using cladistic analysis and the resources of the PGA, we will identify a limited set of single nucleotide polymorphisms (range 3-10 SNPs per gene) that characterize common haplotypes in these candidate genes within persons of African descent and European descent. DNA from the CARDIA Year 10 examination (n = 3,950 subjects) will be genotyped for the selected variants that characterize the common haplotypes. Data on the presence of common variants and haplotypes will be incorporated into the CARDIA Study database. Levels of two important intermediate phenotypes, fibrinogen and C-reactive protein (CRP) were previously determined. Non-invasive assessment of coronary atherosclerosis, defined as the presence of coronary artery calcification (CAC), was obtained on CARDIA participants at the Year 15 exam. Analyses will be stratified by race/ethnicity and focus on the associations of the common haplotypes with fibrinogen, CRP, and CAC measured in early adult life. Secondarily, we will explore possible gene-gene and gene-environment interactions. The proposed multi-disciplinary collaboration should enhance the sensitivity and specificity of efforts to assess the associations of common variation in sets of inflammation/thrombosis candidate genes and cardiovascular risk in young adults.
描述(由申请人提供):生物学的进展表明,动脉粥样硬化可能部分反映了慢性炎症的血管后果。使用有关通过NHLBI计划在华盛顿大学通过NHLBI计划(PGA)产生的一组候选基因的完全序列变化和常见的单倍型的信息,我们建议研究炎症/血栓形成基因与中间定量表型和亚细胞核心菌群的炎症/血栓形成基因在炎症/血栓形成基因中的共同变化的关联(大型,双种族人队列研究。一组25个候选基因涉及途径(细胞因子,趋化因子及其受体;细胞粘附分子;和,凝结蛋白),并包括几种受体配体对。使用Cladistic分析和PGA的资源,我们将确定一组有限的单核苷酸多态性(每个基因3-10个SNP范围3-10个SNP),这些核苷酸是在非洲血统和欧洲血统中这些候选基因中常见的单倍型的表征。 Cardia 10年级检查中的DNA(n = 3,950名受试者)将针对表征常见单倍型的选定变体进行基因分型。有关存在常见变体和单倍型的存在的数据将纳入Cardia研究数据库。先前确定了两种重要的中间表型,纤维蛋白原和C反应蛋白(CRP)的水平。在15年级考试中,在Cardia参与者上获得了冠状动脉粥样硬化的非侵入性评估,该评估被定义为冠状动脉钙化(CAC)。分析将根据种族/种族分析,并将重点放在成年早期生命早期测量的纤维蛋白原,CRP和CAC的共同关联上。其次,我们将探索可能的基因基因和基因环境相互作用。拟议的多学科合作应提高努力的敏感性和特异性,以评估炎症/血栓形成候选基因和年轻人心血管风险的共同变异的关联。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Stuart SISCOVICK其他文献
DAVID Stuart SISCOVICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Stuart SISCOVICK', 18)}}的其他基金
Genome-wide study of sudden cardiac arrest in the community
社区心脏骤停的全基因组研究
- 批准号:
7653036 - 财政年份:2009
- 资助金额:
$ 58.56万 - 项目类别:
Genome-wide study of sudden cardiac arrest in the community
社区心脏骤停的全基因组研究
- 批准号:
7932176 - 财政年份:2009
- 资助金额:
$ 58.56万 - 项目类别:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
脂肪酸代谢和心脏骤停的人类遗传变异
- 批准号:
8011714 - 财政年份:2008
- 资助金额:
$ 58.56万 - 项目类别:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
脂肪酸代谢和心脏骤停的人类遗传变异
- 批准号:
7585808 - 财政年份:2008
- 资助金额:
$ 58.56万 - 项目类别:
HUMAN GENETIC VARIATION IN FATTY ACID METABOLISM AND SUDDEN CARDIAC ARREST
脂肪酸代谢和心脏骤停的人类遗传变异
- 批准号:
7753653 - 财政年份:2008
- 资助金额:
$ 58.56万 - 项目类别:
Maternal Obesity, Fetal Genomics, and Atherosclerotic Metabolic Risk
孕产妇肥胖、胎儿基因组学和动脉粥样硬化代谢风险
- 批准号:
7675389 - 财政年份:2006
- 资助金额:
$ 58.56万 - 项目类别:
Maternal Obesity, Fetal Genomics, and Atherosclerotic Metabolic Risk
孕产妇肥胖、胎儿基因组学和动脉粥样硬化代谢风险
- 批准号:
7486765 - 财政年份:2006
- 资助金额:
$ 58.56万 - 项目类别:
Maternal Obesity, Fetal Genomics, and Atherosclerotic Metabolic Risk
母亲肥胖、胎儿基因组学和动脉粥样硬化代谢风险
- 批准号:
7233309 - 财政年份:2006
- 资助金额:
$ 58.56万 - 项目类别:
Maternal Obesity, Fetal Genomics, and Atherosclerotic Metabolic Risk
母亲肥胖、胎儿基因组学和动脉粥样硬化代谢风险
- 批准号:
7290437 - 财政年份:2006
- 资助金额:
$ 58.56万 - 项目类别:
相似国自然基金
肝癌外周血测序数据中循环肿瘤DNA占比的精确解耦方法研究
- 批准号:62303271
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DNA双链断裂修复蛋白DNA-PKcs致病性移码突变在机体发育和肿瘤发生中的作用
- 批准号:82372716
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
遗传调控的DNA甲基化在多金属复合暴露与糖尿病及其前期发生风险关联中的中介效应
- 批准号:82304091
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
EndoG在小鼠精子线粒体DNA消除中的作用及机制研究
- 批准号:32300953
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
精子miRNA调控早期胚胎DNA甲基化重编程介导抑郁症代际遗传的机制研究
- 批准号:32370629
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
NATIENS:一项 III 期随机双盲研究,以确定史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的机制和最佳治疗
- 批准号:
10217036 - 财政年份:2020
- 资助金额:
$ 58.56万 - 项目类别:
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
NATIENS:一项 III 期随机双盲研究,以确定史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的机制和最佳治疗
- 批准号:
10402818 - 财政年份:2020
- 资助金额:
$ 58.56万 - 项目类别:
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
NATIENS:一项 III 期随机双盲研究,以确定史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的机制和最佳治疗
- 批准号:
10612063 - 财政年份:2020
- 资助金额:
$ 58.56万 - 项目类别:
Non-viral gene therapy for sickle cell anemia
镰状细胞性贫血的非病毒基因治疗
- 批准号:
8293156 - 财政年份:2009
- 资助金额:
$ 58.56万 - 项目类别:
Non-viral gene therapy for sickle cell anemia
镰状细胞性贫血的非病毒基因治疗
- 批准号:
8065383 - 财政年份:2009
- 资助金额:
$ 58.56万 - 项目类别: